Thursday, December 22, 2016

BRIEF-Alcon receives U.S. FDA approval for acrysof iq restor +3.0d multifocal toric intraocular lens

* Alcon - U.S. commercialization expected to start on a

rolling basis in Q1 of 2017 for acrysof iq restor

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)